method of treating an individual with a cannabinoid-sensitive disorder, establishing an optimal dose, treating an individual with a sleep apnea disorder, and

• 收藏
• 分享

专利权人:

PIER PHARMACEUTICALS

发明人:

DAVID CARLEY,PETER LETENDRE

申请号：

BR112013012468

公开号：

BR112013012468A2

申请日:

2011.11.18

申请国别(地区):

BR

年份:

2016

代理人:

摘要：

The present invention provides methods for treating cannabinoid-sensitive disorders with a lose-dose oral cannabinoid which results in delivery of a therapeutic level during an extended clinically-relevant therapeutic window. These methods provide therapeutic dosing while maintaining safe, side effect sparing, levels of a cannabinoid. The present invention also provides methods of determining optimal dosing in treated patients.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/